4//SEC Filing
Bassan Merav 4
Accession 0001213900-23-095419
CIK 0001739174other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:43 PM ET
Size
13.4 KB
Accession
0001213900-23-095419
Insider Transaction Report
Form 4
BiomX Inc.PHGE
Bassan Merav
Chief Development Officer
Transactions
- Disposition to Issuer
Common Stock Options - Right to Buy
2023-12-11−47,500→ 0 totalExercise: $7.02Exp: 2031-03-30→ Common Stock (47,500 underlying) - Award
Common Stock Options - Right to Buy
2023-12-11+12,500→ 12,500 totalExercise: $0.27Exp: 2031-03-30→ Common Stock (12,500 underlying) - Disposition to Issuer
Common Stock Options - Right to Buy
2023-12-11−100,000→ 0 totalExercise: $1.41Exp: 2032-03-29→ Common Stock (100,000 underlying) - Award
Common Stock Options - Right to Buy
2023-12-11+71,429→ 71,429 totalExercise: $0.27Exp: 2032-03-29→ Common Stock (71,429 underlying)
Footnotes (4)
- [F1]On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 47,500 shares of the Issuer's common stock granted to the Reporting Person on March 30, 2021. In exchange, the Reporting Person received a replacement option, for 12,500 shares, having an exercise price of $0.2749 per share.
- [F2]The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 30, 2022, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
- [F3]On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 100,000 shares of the Issuer's common stock granted to the Reporting Person on March 29, 2022. In exchange, the Reporting Person received a replacement option, for 71,429 shares, having an exercise price of $0.2749 per share.
- [F4]The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 29, 2023, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
Documents
Issuer
BiomX Inc.
CIK 0001739174
Entity typeother
Related Parties
1- filerCIK 0001792702
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:43 PM ET
- Size
- 13.4 KB